Analysts Set Teleflex Incorporated (NYSE:TFX) PT at $271.69

Teleflex Incorporated (NYSE:TFX – Get Rating) has been given an average recommendation of “Moderate Buy” by the fifteen research firms that are presently covering the company, Marketbeat Ratings reports. Six analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $271.69.

A number of equities analysts have recently issued reports on TFX shares. StockNews.com raised Teleflex from a “hold” rating to a “buy” rating in a research report on Monday, March 13th. Truist Financial reduced their price target on Teleflex from $260.00 to $250.00 and set a “hold” rating on the stock in a research report on Monday, February 27th. Morgan Stanley upped their price target on Teleflex from $236.00 to $280.00 and gave the stock an “equal weight” rating in a research report on Friday, January 6th. Stephens upped their price target on Teleflex from $280.00 to $295.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 28th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $291.00 price target on shares of Teleflex in a research report on Friday, February 24th.

Institutional Investors Weigh In On Teleflex

Several hedge funds have recently added to or reduced their stakes in the business. Utah Retirement Systems boosted its stake in shares of Teleflex by 0.6% during the 3rd quarter. Utah Retirement Systems now owns 8,368 shares of the medical technology company’s stock worth $1,686,000 after acquiring an additional 47 shares in the last quarter. Tealwood Asset Management Inc. boosted its stake in shares of Teleflex by 1.6% during the 3rd quarter. Tealwood Asset Management Inc. now owns 3,138 shares of the medical technology company’s stock worth $632,000 after acquiring an additional 48 shares in the last quarter. First Horizon Advisors Inc. boosted its stake in shares of Teleflex by 60.0% during the 4th quarter. First Horizon Advisors Inc. now owns 128 shares of the medical technology company’s stock worth $32,000 after acquiring an additional 48 shares in the last quarter. Mercer Global Advisors Inc. ADV boosted its stake in shares of Teleflex by 3.5% during the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 1,411 shares of the medical technology company’s stock worth $284,000 after acquiring an additional 48 shares in the last quarter. Finally, Ensign Peak Advisors Inc boosted its stake in shares of Teleflex by 0.3% during the 3rd quarter. Ensign Peak Advisors Inc now owns 16,692 shares of the medical technology company’s stock worth $3,362,000 after acquiring an additional 50 shares in the last quarter. 93.82% of the stock is owned by hedge funds and other institutional investors.

Teleflex Stock Performance

Shares of NYSE:TFX opened at $235.84 on Thursday. The company has a market capitalization of $11.07 billion, a price-to-earnings ratio of 30.71, a price-to-earnings-growth ratio of 2.36 and a beta of 0.98. Teleflex has a 52 week low of $182.65 and a 52 week high of $356.72. The company has a quick ratio of 1.43, a current ratio of 2.43 and a debt-to-equity ratio of 0.40. The firm has a 50 day moving average of $240.88 and a 200 day moving average of $229.35.

Teleflex (NYSE:TFX – Get Rating) last issued its quarterly earnings data on Thursday, February 23rd. The medical technology company reported $3.52 EPS for the quarter, topping analysts’ consensus estimates of $3.44 by $0.08. The company had revenue of $758.00 million during the quarter, compared to the consensus estimate of $760.29 million. Teleflex had a net margin of 13.01% and a return on equity of 15.87%. Teleflex’s revenue for the quarter was down .5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $3.60 earnings per share. On average, sell-side analysts predict that Teleflex will post 13.29 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 15th. Shareholders of record on Friday, March 3rd were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.58%. The ex-dividend date of this dividend was Thursday, March 2nd. Teleflex’s payout ratio is 17.71%.

Teleflex Company Profile

(Get Rating)

Teleflex, Inc provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The firm designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications.